Phaseline

Companies › Apellis Pharmaceuticals

Apellis Pharmaceuticals: clinical trials, targets and expected readouts

3 active drug programs in 6 registered trials: 4 Phase 2, 1 Phase 3, 1 Phase 1; Genitourinary, Hematology, Oncology, Ophthalmology; next expected readout Jun 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Pegcetacoplan
Complement C3 inhibitor
C3Phase 3C3G; Paroxysmal Nocturnal Hemoglobinuria (PNH); Fallopian Tube Carcinosarcoma; Metastatic Pancreatic Ductal AdenocarcinomaJul 2027
APL-3007
Complement C3 inhibitor
C3Phase 2Geographic Atrophy Secondary to Age-related Macular DegenerationJun 2027
APL2
Complement C3 inhibitor
C3Phase 2FSGSOct 2029

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07215390APL-3007Phase 2Geographic Atrophy Secondary to Age-related Macular DegenerationOphthalmologyJun 2027
NCT05809531PegcetacoplanPhase 3C3GGenitourinaryJul 2027
NCT07214298PegcetacoplanPhase 1Metastatic Pancreatic Ductal AdenocarcinomaOncologyFeb 2028
NCT04919629PegcetacoplanPhase 2Fallopian Tube CarcinosarcomaOncologyApr 2028
NCT04901936PegcetacoplanPhase 2Paroxysmal Nocturnal Hemoglobinuria (PNH)HematologyDec 2028
NCT07213960APL2Phase 2FSGSGenitourinaryOct 2029

Targets

C3 (3)

Companies with the same targets

Annexon Kodiak Sciences Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Shenyang Sunshine Pharmaceutical Swedish Orphan Biovitrum

Companies built like this

Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Kind Pharmaceuticals Clinique Ovo Sitala Bio Chengdu Suncadia Medicine

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.